CLIA regulations set basic requirements for testing external QC materials, but so far, a comprehensive approach to QC that suits regulators and a majority of the lab community has not emerged. Now the Clinical and Laboratory Standards Institute has published a long-awaited guideline based on risk management that aims to fill this gap.
Antinuclear antibody test results tend to be used inappropriately by some clinicians as a screening test for autoimmune rheumatic diseases. Labs have a key role in educating physicians about the limitations of the various testing methods and in making the best use of the tests.
CDC’s efforts to standardize lipid and lipoprotein measurements have been invaluable to improving public health and have helped laboratories deliver meaningful test results to assess the risk of cardiovascular disease. In anticipation of the soon-to-be-released ATP IV guidelines, this review of the agency’s Lipid Standardization Program provides insight on what the panel is considering.
The controversy recently heated up over use of the prostate-specific antigen test as a screening tool for prostate cancer. The influential U.S. Preventive Services Task Force advised against PSA testing in healthy men, citing that the potential harms associated with screening and treatment outweighed the benefits of detecting early stage prostate cancer.
AACC’s secretary announced the results of the association’s 2011 Election.
Download the entire issue
D-dimer in Pulmonary EmbolismChanges Coming to Proficiency Testing